Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of intravenous tapentadol solution for injection for the treatment of post-surgical pain in children aged from birth to less than 2 years, including preterm neonates
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Tapentadol (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
- 06 Jul 2016 Planned end date changed from 1 Aug 2016 to 30 Dec 2016.
- 06 May 2016 Planned End Date changed from 23 Aug 2016 to 16 Sep 2016.
- 04 Mar 2015 New trial record